ArticleCancer immunology, immunotherapy : CII2024

GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration.

Wenjing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.